Newron Pharmaceuticals SpA

NEW
XTER:NP5 (Italy)  
€ 13.05 +0.15 (+1.16%) Jul 22
At Loss
Market Cap:
€ 271.70M ($ 309.14M)
Enterprise V:
€ 280.99M ($ 319.71M)
Volume:
2.83K
Avg Vol (2M):
3.56K
Trade In:
Volume:
2.83K
At Loss

Newron Pharmaceuticals SpA (XTER:NP5) Dividend

Newron Pharmaceuticals SpA (XTER:NP5) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -3.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: XTER:NP5 Dividend

Does Newron Pharmaceuticals SpA (XTER:NP5) pay a dividend?

Newron Pharmaceuticals SpA (XTER:NP5) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Newron Pharmaceuticals SpA pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Newron Pharmaceuticals SpA has returned capital to shareholders via buybacks at a rate of -3.9% over the past 3 years.

What are dividend-paying alternatives to Newron Pharmaceuticals SpA?

For dividend-paying alternatives in Newron Pharmaceuticals SpA's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.